Donepezil enhances understanding of degraded speech in Alzheimer's disease.

Abstract

Auditory dysfunction under complex, dynamic listening conditions is a clinical hallmark of Alzheimer's disease (AD) but challenging to measure and manage. Here, we assessed understanding of sinewave speech (a paradigm of degraded speech perception) and general cognitive abilities in 17 AD patients, before and following a 10 mg dose of donepezil. Relative to healthy older individuals, patients had impaired sinewave speech comprehension that was selectively ameliorated by donepezil. Our findings demonstrate impaired perception of degraded speech in AD but retained perceptual learning capacity that can be harnessed by acetylcholinesterase inhibition, with implications for designing communication interventions and acoustic environments in dementia.

• Authors: Chris J D Hardy, Yun T Hwang, Rebecca L Bond, Charles R Marshall, Basil H Ridha, Sebastian J Crutch, Martin N Rossor, Jason D Warren
• Journal: Annals of clinical and translational neurology (Ann Clin Transl Neurol) Vol. 4 Issue 11 Pg. 835-840 (11 2017) ISSN: 2328-9503 [Print] United States
• PMID: 29159197 (Publication Type: Journal Article)